Eswar Bio Briquette India Profile
Key Indicators
- Authorised Capital ₹ 7.30 M
- Paid Up Capital ₹ 7.30 M
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 8.00 M
- Revenue Growth -7.38%
- Profit Growth -118.55%
- Ebitda -15.22%
- Net Worth -222.27%
- Total Assets 1.13%
About Eswar Bio Briquette India
Eswar Bio Briquette India Private Limited (EBBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 September 2012 and has a history of 12 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 7.30 M and a paid-up capital of Rs 7.30 M.
The company currently has active open charges totaling ₹8.00 M.
Rajani Yarlagadda, Ramadevi Amaram, and Sreekanth Kolla serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U37100TG2012PTC083172
-
Company No.
083172
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Sep 2012
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Eswar Bio Briquette India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreekanth Kolla
|
Managing Director | 18-Sep-2012 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Rajani Yarlagadda
|
Director | 18-Sep-2012 | Current |
|
Ramadevi Amaram
|
Director | 04-Nov-2015 | Current |
Financial Performance of Eswar Bio Briquette India.
Eswar Bio Briquette India Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.38% decrease. The company also saw a substantial fall in profitability, with a 118.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 222.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eswar Bio Briquette India?
In 2017, Eswar Bio Briquette India had a promoter holding of 84.21% and a public holding of 15.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ehs Minerals Private LimitedRajani Yarlagadda is a mutual person
-
Rx-Infinity Therapeutics Private Limited
Ramadevi Amaram is a mutual person
Charges (Loans)
₹8.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2013 | Others | ₹8.00 M | Open |
How Many Employees Work at Eswar Bio Briquette India?
Unlock and access historical data on people associated with Eswar Bio Briquette India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eswar Bio Briquette India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eswar Bio Briquette India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
